This treatment effect was dependent on CD4 and CD8 T cells, as well as macrophages, highlighting the complex relationship between constituents of the TME, and the potential need for multi-targeted therapy to overcome tumour-mediated immunosuppression. This evidence concerns the gene CD4 and neoplasm.